Singh PK - Search Results

1

Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.

Singh C, Naik BN, Pandey S, Biswas B, Pati BK, Verma M, Singh PK. Singh C, et al. Among authors: singh pk. Epidemiol Infect. 2021 Oct 11;149:e224. doi: 10.1017/S0950268821002247. Epidemiol Infect. 2021. PMID: 34632972 Free PMC article.

2

Clinico-Epidemiological Profile of Breakthrough COVID-19 Infection among Vaccinated Beneficiaries from a COVID-19 Vaccination Centre in Bihar, India.

Singh CM, Singh PK, Naik BN, Pandey S, Nirala SK, Singh PK. Singh CM, et al. Among authors: singh pk. Ethiop J Health Sci. 2022 Jan;32(1):15-26. doi: 10.4314/ejhs.v32i1.3. Ethiop J Health Sci. 2022. PMID: 35250213 Free PMC article.

3

Sero-epidemiological survey of SARS-Cov2 in urban slums of a capital city: A cross- sectional study.

Nirala SK, Naik BN, Chaudhary N, Ranjan A, Mahto M, Pandey S, Singh CM, Singh PK. Nirala SK, et al. Among authors: singh cm, singh pk. J Family Med Prim Care. 2022 Jun;11(6):2709-2716. doi: 10.4103/jfmpc.jfmpc_2127_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119186 Free PMC article.

4

Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.

Mahto M, Banerjee A, Biswas B, Kumar S, Agarwal N, Singh PK. Mahto M, et al. Among authors: singh pk. Am J Blood Res. 2021 Feb 15;11(1):44-52. eCollection 2021. Am J Blood Res. 2021. PMID: 33796388 Free PMC article.

5

Clinicodemographic profile and predictors of poor outcome in hospitalised COVID-19 patients: a single-centre, retrospective cohort study from India.

Tiwari L, Gupta P, N Y, Banerjee A, Kumar Y, Singh PK, Ranjan A, Singh CM, Singh PK. Tiwari L, et al. Among authors: singh cm, singh pk. BMJ Open. 2022 Jun 1;12(6):e056464. doi: 10.1136/bmjopen-2021-056464. BMJ Open. 2022. PMID: 35649611 Free PMC article.

6

Investigation of an acute surge of COVID-19 associated mucormycosis (CAM) cases reported to a tertiary health care institution in Bihar, India.

Singh CM, Naik BN, Pandey S, Singh PK, Rajath Rao UR, Kokkayil P, Bhavana K, Singh PK. Singh CM, et al. Among authors: singh pk. J Family Med Prim Care. 2022 Jun;11(6):2802-2810. doi: 10.4103/jfmpc.jfmpc_1909_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119217 Free PMC article.

7

The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness.

Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, Singh V, Singh PK. Kumar N, et al. Among authors: singh pk, singh v. Indian J Crit Care Med. 2021 Oct;25(10):1113-1119. doi: 10.5005/jp-journals-10071-24000. Indian J Crit Care Med. 2021. PMID: 34916742 Free PMC article.

8

Persistent positivity of SARS-CoV-2 nucleic acid in asymptomatic healthcare worker: infective virion or inactive nucleic acid?

Tiwari L, Gupta P, Singh CM, Singh PK. Tiwari L, et al. Among authors: singh cm, singh pk. BMJ Case Rep. 2021 Mar 3;14(3):e241087. doi: 10.1136/bcr-2020-241087. BMJ Case Rep. 2021. PMID: 33658220 Free PMC article.

9

Gargling with 7.5% Sodium Bicarbonate Solution for SARS-CoV-2 Viremia Clearance: Our Institutional Clinical Experience.

Kumar N, Kumar A, Mahto M, Singh PK. Kumar N, et al. Among authors: singh pk. Indian J Crit Care Med. 2021 Jul;25(7):791-794. doi: 10.5005/jp-journals-10071-23901. Indian J Crit Care Med. 2021. PMID: 34316174 Free PMC article.

However, still larger studies are required to ascertain the benefit of gargling for different stages of COVID-19 patients with keeping in mind the important variables suggestive of viremia clearance. HOW TO CITE THIS ARTICLE: Kumar N, Kumar A, Mahto M, Singh PK. Gar …

However, still larger studies are required to ascertain the benefit of gargling for different stages of COVID-19 patients with keeping in mi …

10

Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center.

Kumari P, Kumar A, Sinha C, Kumar A, Singh PK, Arun SK. Kumari P, et al. Among authors: singh pk. Indian J Crit Care Med. 2021 Apr;25(4):467-469. doi: 10.5005/jp-journals-10071-23787. Indian J Crit Care Med. 2021. PMID: 34045817 Free PMC article.

HOW TO CITE THIS ARTICLE: Kumari P, Kumar A, Sinha C, Kumar A, Singh PK, Arun SK. Off-label Use of Itolizumab in Patients with COVID-19 ARDS: Our Clinical Experience in a Dedicated COVID Center. ...

HOW TO CITE THIS ARTICLE: Kumari P, Kumar A, Sinha C, Kumar A, Singh PK, Arun SK. Off-label Use of Itolizumab in Patients with …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,327 results

Search Page